Product NDC: | 37000-737 |
Proprietary Name: | Nioxin Scalp Treatment System 2 |
Non Proprietary Name: | Ensulizole and Sulisobenzone |
Active Ingredient(s): | 41.2; 16.48 mg/mL; mg/mL & nbsp; Ensulizole and Sulisobenzone |
Administration Route(s): | TOPICAL |
Dosage Form(s): | LIQUID |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 37000-737 |
Labeler Name: | Procter & Gamble Manufacturing Company |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part352 |
Marketing Category: | OTC MONOGRAPH NOT FINAL |
Start Marketing Date: | 20110501 |
Package NDC: | 37000-737-20 |
Package Description: | 1 BOTTLE, PLASTIC in 1 CARTON (37000-737-20) > 200 mL in 1 BOTTLE, PLASTIC |
NDC Code | 37000-737-20 |
Proprietary Name | Nioxin Scalp Treatment System 2 |
Package Description | 1 BOTTLE, PLASTIC in 1 CARTON (37000-737-20) > 200 mL in 1 BOTTLE, PLASTIC |
Product NDC | 37000-737 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Ensulizole and Sulisobenzone |
Dosage Form Name | LIQUID |
Route Name | TOPICAL |
Start Marketing Date | 20110501 |
Marketing Category Name | OTC MONOGRAPH NOT FINAL |
Labeler Name | Procter & Gamble Manufacturing Company |
Substance Name | ENSULIZOLE; SULISOBENZONE |
Strength Number | 41.2; 16.48 |
Strength Unit | mg/mL; mg/mL |
Pharmaceutical Classes |